tiprankstipranks
Trending News
More News >
Grand Brilliance Group Holdings Limited (HK:8372)
:8372
Hong Kong Market

Grand Brilliance Group Holdings Limited (8372) AI Stock Analysis

Compare
1 Followers

Top Page

HK

Grand Brilliance Group Holdings Limited

(8372)

Rating:76Outperform
Price Target:
Grand Brilliance Group Holdings Limited demonstrates robust financial stability with strong equity and low debt levels, supporting its resilience and operational efficiency. The positive technical indicators suggest upward momentum, enhancing its stock appeal. However, there is room for improvement in cash flow generation and net profit margins. The valuation is fair with a moderate P/E ratio and a decent dividend yield, making the stock a balanced investment option with potential for growth.

Grand Brilliance Group Holdings Limited (8372) vs. iShares MSCI Hong Kong ETF (EWH)

Grand Brilliance Group Holdings Limited Business Overview & Revenue Model

Company DescriptionGrand Brilliance Group Holdings Limited (8372) is a company based in Hong Kong, primarily engaged in the provision of medical devices and related services. The company focuses on offering a wide range of medical equipment, including diagnostic and therapeutic devices, to healthcare providers and facilities. Their products and services cater to various medical specialties, ensuring high-quality healthcare delivery across the region.
How the Company Makes MoneyGrand Brilliance Group Holdings Limited generates revenue through the sale and distribution of medical devices and equipment. The company collaborates with healthcare providers, hospitals, and clinics to supply essential medical products, ensuring they meet the demands of the healthcare sector. Revenue streams include direct sales of equipment, long-term supply contracts, and maintenance services. Key partnerships with manufacturers and healthcare institutions further bolster their market position and contribute to their earnings.

Grand Brilliance Group Holdings Limited Financial Statement Overview

Summary
Grand Brilliance Group Holdings Limited presents a solid financial position with strong equity ratios and minimal debt, indicating stability and financial flexibility. However, there are areas for improvement, particularly in cash flow generation and net profit margins, which have shown some pressure. The company's revenue growth and operational efficiency are commendable, though continued focus on margin improvement and cash flow management will be crucial for sustaining financial health and shareholder value.
Income Statement
75
Positive
The company demonstrates solid revenue growth with a Revenue Growth Rate of 6.78% from 2023 to 2024 and maintains a strong Gross Profit Margin of 51.20%. However, the Net Profit Margin has slightly decreased to 9.59% from the prior year's 9.86%, indicating some pressure on profitability. The EBIT Margin of 6.41% suggests operational efficiency, though it has declined from the previous year. Overall, the income statement shows stability with room for improvement in net profit margins.
Balance Sheet
82
Very Positive
The balance sheet is robust with a high Equity Ratio of 90.27%, indicating a strong equity base relative to total assets. The Debt-to-Equity Ratio is low at 0.01, reflecting minimal leverage and suggesting financial stability. Return on Equity is commendable at 7.60%, indicating effective use of equity to generate profits. The balance sheet reflects strong financial health with low debt levels and efficient equity utilization.
Cash Flow
68
Positive
The cash flow statement shows a decline in Operating Cash Flow from HK$12.66M to HK$6.72M, indicating reduced cash generation from operations. Free Cash Flow has also declined, though it remains positive at HK$4.91M. The Free Cash Flow to Net Income Ratio is 0.63, suggesting adequate, but declining, cash flow relative to net income. Despite these challenges, the company maintains positive free cash flow, which is a strength but highlights the need for improving operational cash generation.
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue82.29M81.90M76.70M71.98M70.24M67.23M
Gross Profit42.01M41.94M39.51M36.35M33.62M36.37M
EBITDA5.32M13.20M14.09M9.87M12.91M14.79M
Net Income8.45M7.86M7.56M4.05M7.86M9.57M
Balance Sheet
Total Assets116.13M114.50M115.25M110.32M112.01M104.89M
Cash, Cash Equivalents and Short-Term Investments66.48M60.47M61.86M55.74M70.26M70.64M
Total Debt4.20M1.43M4.45M4.48M4.87M811.00K
Total Liabilities11.50M11.22M16.58M16.82M18.96M16.41M
Stockholders Equity104.77M103.33M98.67M93.51M93.05M88.48M
Cash Flow
Free Cash Flow9.28M4.91M12.60M-4.12M5.62M21.41M
Operating Cash Flow10.11M6.72M12.66M-3.33M6.01M21.63M
Investing Cash Flow646.00K-395.00K-510.00K-3.96M-82.00K623.00K
Financing Cash Flow-5.67M-7.42M-6.40M-7.58M-6.36M-5.55M

Grand Brilliance Group Holdings Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.12
Price Trends
50DMA
0.12
Positive
100DMA
0.11
Positive
200DMA
0.10
Positive
Market Momentum
MACD
<0.01
Positive
RSI
57.11
Neutral
STOCH
36.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8372, the sentiment is Positive. The current price of 0.12 is above the 20-day moving average (MA) of 0.12, above the 50-day MA of 0.12, and above the 200-day MA of 0.10, indicating a bullish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 57.11 is Neutral, neither overbought nor oversold. The STOCH value of 36.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8372.

Grand Brilliance Group Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
HK$95.20M10.088.84%2.10%-3.17%8.16%
60
Neutral
HK$15.58B5.65-7.43%4.32%11.60%-21.06%
50
Neutral
$8.37B-9.66%-44.43%-281.08%
45
Neutral
HK$268.11M-30.23%5.79%-780.00%
44
Neutral
HK$22.55M116.470.88%8.34%
38
Underperform
HK$36.80M-9.50%-58.07%-303.40%
34
Underperform
HK$34.02M0.67
-68.00%25.80%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8372
Grand Brilliance Group Holdings Limited
0.12
0.02
20.00%
HK:8196
China TianYF Holdings Group Limited
1.59
0.21
15.22%
HK:8081
Hang Tai Yue Group Holdings Ltd.
0.05
0.00
0.00%
HK:8056
Life Concepts Holdings Limited
0.30
-0.04
-11.76%
HK:8137
Honbridge Holdings
0.58
0.38
192.93%
HK:8186
M-Resources Group Limited
0.20
-0.84
-80.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 07, 2025